Gateway Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Gateway Wealth Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.95M	Buy	19,654 +12,495	+175%	+$2.58M	0.15%	157
2025 Q4	$1.48M	Buy	7,159 +692	+11%	+$138K	0.16%	145
2025 Q3	$1.16M	Buy	6,467 +340	+6%	+$57.9K	0.16%	145
2025 Q2	$988K	Buy	6,127 +111	+2%	+$17.7K	0.19%	120
2025 Q1	$1.02M	Buy	6,016 +658	+12%	+$114K	0.23%	109
2024 Q4	$890K	Buy	+5,358	New	+$916K	0.23%	102
2024 Q3	–	Sell	-1,656	Closed	-$255K	–	277
2024 Q2	$255K	Buy	1,656 +61	+4%	+$9.15K	0.08%	224
2024 Q1	$245K	Sell	1,595 -217	-12%	-$33.1K	0.09%	201
2023 Q4	$286K	Buy	+1,812	New	+$260K	0.12%	163

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Gateway Wealth Partners's FBT Position: Q1 2026 in Review

Gateway Wealth Partners increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 175% in Q1 2026, buying an estimated $2.58M and bringing the position to 19,654 shares worth $3.95M. The position accounts for 0.15% of the portfolio, ranked #157.

Gateway Wealth Partners first reported a position in FBT in Q4 2023 and has held it in 9 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Gateway Wealth Partners held 19,654 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.95M as of Q1 2026.
Gateway Wealth Partners bought 12,495 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.58M.
First Trust NYSE Arca Biotechnology Index Fund made up 0.15% of Gateway Wealth Partners's portfolio in Q1 2026, its #157 holding.
Gateway Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 9 quarters since.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Gateway Wealth Partners's 13F filing for Q1 2026, filed 15 May 2026.